Latest Blog Posts Tagged "NTN"
May 21, 2013
In April, we reported on disappointing clinical trial results of Ceregene's trophic factor therapy CERE-120. Today, additional data is announced that could be instructional moving forward.
May 08, 2013
Check out this special breaking news Hot Topics Webinar: "The Future of Trophic Factors," which addresses recent clinical trial results from Ceregene and their therapy CERE-120.
April 26, 2013
Dave Iverson reports on recent disappointing clinical trial results of Ceregene's trophic factor therapy CERE-120.
April 25, 2013
Sign up for a breaking news Webinar (May 1 at noon ET) that will address recent clinical study results from the San Diego-based biotech Ceregene.
April 19, 2013
Ceregene today announced disappointing results from its second Phase 2 trial of CERE-120, an experimental gene therapy treatment for PD. The drug's future development is unclear.